Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (56)

Latest Posts

About This Stock More About This Stock
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EDT
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EDT
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read
Biotech Avoids Tech Wreck Of June 9
Article By: Rod Raynovich
Monday, June 12, 2017 1:48 AM EDT
A big part of 2017 investing strategy will be picking the right sector. Healthcare appears to offer modest returns with a dividend play.
In this article: BAC, BMY, JNJ, MRK, PFE, IBB, AAPL, AMZN, GILD, NFLX, NVDA, TSLA, SMH, XBI, XLE, XLF, XLV, FB, ABBV, GOOGL, BLUE
Read
ASCO Update: Movers On The News - INCY, PBYI, RHHBY
Article By: Rod Raynovich
Tuesday, June 6, 2017 2:00 AM EDT
A lot of the product news is already “baked into” stock prices but here is a brief summary of big movers on clinical news updates. The bellwether XBI peaked at $71.72 yesterday and is down 0.62% to $70.66.
In this article: BMY, RHHBY, INCY, XBI, PUMA, BLUE
Read
Large Cap Biopharmaceutical Valuations: Q1 2017
Article By: Rod Raynovich
Monday, May 8, 2017 8:45 PM EDT
Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the valuation metrics.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!